Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HS25
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 41 | 45 | PF00656 | 0.654 |
CLV_NRD_NRD_1 | 126 | 128 | PF00675 | 0.543 |
CLV_NRD_NRD_1 | 163 | 165 | PF00675 | 0.461 |
CLV_NRD_NRD_1 | 176 | 178 | PF00675 | 0.425 |
CLV_NRD_NRD_1 | 251 | 253 | PF00675 | 0.523 |
CLV_NRD_NRD_1 | 255 | 257 | PF00675 | 0.569 |
CLV_PCSK_FUR_1 | 130 | 134 | PF00082 | 0.534 |
CLV_PCSK_KEX2_1 | 126 | 128 | PF00082 | 0.543 |
CLV_PCSK_KEX2_1 | 132 | 134 | PF00082 | 0.559 |
CLV_PCSK_KEX2_1 | 144 | 146 | PF00082 | 0.577 |
CLV_PCSK_KEX2_1 | 163 | 165 | PF00082 | 0.461 |
CLV_PCSK_KEX2_1 | 178 | 180 | PF00082 | 0.435 |
CLV_PCSK_KEX2_1 | 255 | 257 | PF00082 | 0.547 |
CLV_PCSK_PC1ET2_1 | 132 | 134 | PF00082 | 0.552 |
CLV_PCSK_PC1ET2_1 | 144 | 146 | PF00082 | 0.589 |
CLV_PCSK_PC1ET2_1 | 178 | 180 | PF00082 | 0.435 |
CLV_PCSK_SKI1_1 | 145 | 149 | PF00082 | 0.636 |
DOC_CKS1_1 | 235 | 240 | PF01111 | 0.629 |
DOC_CYCLIN_yClb3_PxF_3 | 119 | 127 | PF00134 | 0.470 |
DOC_USP7_MATH_1 | 6 | 10 | PF00917 | 0.539 |
DOC_USP7_UBL2_3 | 144 | 148 | PF12436 | 0.567 |
DOC_WW_Pin1_4 | 184 | 189 | PF00397 | 0.501 |
DOC_WW_Pin1_4 | 234 | 239 | PF00397 | 0.640 |
LIG_14-3-3_CanoR_1 | 21 | 31 | PF00244 | 0.536 |
LIG_eIF4E_1 | 95 | 101 | PF01652 | 0.544 |
LIG_FHA_1 | 228 | 234 | PF00498 | 0.619 |
LIG_FHA_1 | 77 | 83 | PF00498 | 0.677 |
LIG_FHA_2 | 153 | 159 | PF00498 | 0.449 |
LIG_FHA_2 | 235 | 241 | PF00498 | 0.514 |
LIG_GBD_Chelix_1 | 100 | 108 | PF00786 | 0.539 |
LIG_LIR_Gen_1 | 143 | 153 | PF02991 | 0.504 |
LIG_LIR_Gen_1 | 155 | 165 | PF02991 | 0.476 |
LIG_LIR_Gen_1 | 25 | 35 | PF02991 | 0.702 |
LIG_LIR_Gen_1 | 92 | 102 | PF02991 | 0.550 |
LIG_LIR_Nem_3 | 103 | 108 | PF02991 | 0.418 |
LIG_LIR_Nem_3 | 143 | 149 | PF02991 | 0.482 |
LIG_LIR_Nem_3 | 155 | 160 | PF02991 | 0.457 |
LIG_LIR_Nem_3 | 25 | 31 | PF02991 | 0.550 |
LIG_LIR_Nem_3 | 59 | 65 | PF02991 | 0.561 |
LIG_LIR_Nem_3 | 92 | 98 | PF02991 | 0.483 |
LIG_SH2_CRK | 105 | 109 | PF00017 | 0.457 |
LIG_SH2_CRK | 146 | 150 | PF00017 | 0.486 |
LIG_SH2_SRC | 216 | 219 | PF00017 | 0.595 |
LIG_SH2_STAP1 | 157 | 161 | PF00017 | 0.468 |
LIG_SH2_STAP1 | 65 | 69 | PF00017 | 0.544 |
LIG_SH2_STAT3 | 20 | 23 | PF00017 | 0.642 |
LIG_SH2_STAT5 | 204 | 207 | PF00017 | 0.612 |
LIG_SH2_STAT5 | 236 | 239 | PF00017 | 0.513 |
LIG_SH2_STAT5 | 250 | 253 | PF00017 | 0.462 |
LIG_SH2_STAT5 | 69 | 72 | PF00017 | 0.539 |
LIG_SH3_3 | 116 | 122 | PF00018 | 0.458 |
LIG_SH3_3 | 34 | 40 | PF00018 | 0.697 |
LIG_SUMO_SIM_anti_2 | 240 | 245 | PF11976 | 0.424 |
LIG_TYR_ITAM | 92 | 108 | PF00017 | 0.547 |
LIG_TYR_ITIM | 93 | 98 | PF00017 | 0.480 |
MOD_CK1_1 | 9 | 15 | PF00069 | 0.528 |
MOD_CK2_1 | 234 | 240 | PF00069 | 0.497 |
MOD_GlcNHglycan | 12 | 15 | PF01048 | 0.630 |
MOD_GSK3_1 | 6 | 13 | PF00069 | 0.517 |
MOD_NEK2_1 | 10 | 15 | PF00069 | 0.566 |
MOD_NEK2_1 | 191 | 196 | PF00069 | 0.589 |
MOD_PKA_2 | 227 | 233 | PF00069 | 0.673 |
MOD_Plk_1 | 191 | 197 | PF00069 | 0.518 |
MOD_Plk_4 | 152 | 158 | PF00069 | 0.454 |
MOD_Plk_4 | 65 | 71 | PF00069 | 0.559 |
MOD_ProDKin_1 | 184 | 190 | PF00069 | 0.499 |
MOD_ProDKin_1 | 234 | 240 | PF00069 | 0.635 |
TRG_DiLeu_BaEn_1 | 96 | 101 | PF01217 | 0.536 |
TRG_DiLeu_BaLyEn_6 | 178 | 183 | PF01217 | 0.555 |
TRG_ENDOCYTIC_2 | 105 | 108 | PF00928 | 0.457 |
TRG_ENDOCYTIC_2 | 146 | 149 | PF00928 | 0.483 |
TRG_ENDOCYTIC_2 | 157 | 160 | PF00928 | 0.457 |
TRG_ENDOCYTIC_2 | 165 | 168 | PF00928 | 0.393 |
TRG_ENDOCYTIC_2 | 95 | 98 | PF00928 | 0.486 |
TRG_ER_diArg_1 | 126 | 128 | PF00400 | 0.543 |
TRG_ER_diArg_1 | 162 | 164 | PF00400 | 0.480 |
TRG_ER_diArg_1 | 195 | 198 | PF00400 | 0.634 |
TRG_ER_diArg_1 | 254 | 256 | PF00400 | 0.569 |
TRG_NLS_MonoExtC_3 | 251 | 256 | PF00514 | 0.565 |
TRG_Pf-PMV_PEXEL_1 | 181 | 185 | PF00026 | 0.587 |
TRG_Pf-PMV_PEXEL_1 | 198 | 202 | PF00026 | 0.583 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3B4 | Leptomonas seymouri | 71% | 87% |
A0A0S4J2A8 | Bodo saltans | 46% | 78% |
A0A1X0NL02 | Trypanosomatidae | 60% | 95% |
A0A3S5H594 | Leishmania donovani | 100% | 83% |
A4H3V0 | Leishmania braziliensis | 92% | 100% |
C9ZY18 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 60% | 93% |
E9AK12 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 100% |
Q9BLQ5 | Leishmania major | 96% | 100% |
V5ATQ3 | Trypanosoma cruzi | 60% | 96% |